This technology relates to a smart window that automatically opens and closes using a bidirectional pulley and wire drive system that moves the window within the frame.
Existing automatic windows have complex drive mechanisms and lack stability in bidirectional operation.
To address this, the technology utilizes a drive motor, forward/reverse pulleys, wires, and a shaft to provide stable, automatic, bidirectional window operation.
This technology relates to a biomarker for the early diagnosis of cerebral amyloid-beta accumulation and associated diseases through blood tests.
Cerebral amyloid-beta accumulation progresses even before clinical symptoms appear, but a simple blood test for early detection has been lacking.
This technology's biomarker can detect cerebral amyloid-beta accumulation in the blood of cognitively normal individuals and those with mild cognitive impairment even before clinical symptoms emerge, making it a convenient and useful tool for the early diagnosis of related diseases.
This technology concerns an anti-cancer theranostic agent that is activated in the tumor's hypoxic environment and inhibits angiogenesis.
Tumor hypoxia has been a challenge, as it promotes cancer cell invasion and metastasis and increases the expression of drug resistance genes, thereby complicating treatment.
This technology combines a tumor-targeting group, a hypoxia-responsive linker, and a prodrug to selectively activate the drug in tumor tissue and deliver angiogenesis-inhibiting effects, thereby enabling highly targeted anti-cancer treatment and diagnosis.
This technology is a plastic fluorescent panel-based system and method for real-time monitoring of radiation irradiated by a radiation therapy device.
During radiation therapy, accurately verifying the irradiated dose in real-time was challenging, leading to limitations in treatment quality control.
This technology uses a plastic fluorescent panel on the front of the gantry to generate visible light corresponding to the amount of radiation transmitted. A processor then analyzes the size and color of the dose distribution map captured by a camera to measure and output the dose in real-time.
This technology describes a method for enhancing extracellular vesicle secretion through the inhibition of SCOTIN protein expression or activity, and a method for producing extracellular vesicles using this approach.
The limited quantity of extracellular vesicles secreted from cells has restricted their application in areas such as diagnostics, therapeutics, and cosmetics.
This technology identifies the correlation between SCOTIN protein expression/activity inhibition and enhanced extracellular vesicle secretion, thereby increasing the number of vesicles secreted within a given period and improving the efficiency of extracellular vesicle production.
This technology relates to a vehicle braking system comprising a pair of brake members and a cylinder unit positioned adjacent to the driving wheels, and an interlocking wire connecting them.
Existing vehicles faced accident risks such as slipping or overturning due to brake malfunctions, sudden acceleration, or when parked on inclines.
To address this, this technology allows the cylinder rod to sequentially descend and make contact with the ground, lifting the driving wheels. This reduces driving speed and prevents slipping and overturning, enabling safe braking even in uncontrollable situations such as sudden acceleration.
This technology provides a gel polymer electrolyte comprising an acrylonitrile-based polymer with an azide group and tetrazolium that self-crosslinks it, along with its manufacturing method.
Conventional gel polymer electrolytes faced limitations in simultaneously achieving both mechanical strength and ionic conductivity.
This technology forms a dual continuous phase structure with a positively charged tetrazolium cross-linked polymer, negatively charged counter ions, and a liquid electrolyte, thereby simultaneously providing excellent lithium ion conduction efficiency and mechanical strength.
This technology relates to a composition for culturing brain immune cells comprising Matrigel and Annexin A1 (ANXA1), and a method for preparing the same.
Existing in vitro culture materials have made it difficult to reproduce normal brain immune responses and control the overexpression of brain immune cells.
This technology adds Annexin A1 to Matrigel to create a culture environment similar to the human brain, thereby enhancing the viability and stability of astrocytes and microglia and suppressing reactive overexpression.
This technology relates to a method for producing phosphorylated starch with improved properties by phosphorylating starch through the addition of phytic acid, a natural product.
Existing modified starches, produced using chemical substances, faced limitations in terms of safety and consumer acceptance.
This technology phosphorylates starch with natural phytic acid, improving transparency, solubility, swelling power, and storage stability. As a result, it can replace chemically modified starches and be widely utilized in the food industry.
This technology is an ultrasound-nuclear medicine fusion portable imaging device that simultaneously provides anatomical, functional, and biochemical information of the human body.
Existing fusion imaging devices, such as PET/CT and SPECT/CT, have limitations due to high radiation exposure and difficulty in real-time localization.
This technology fuses an ultrasound transducer and a gamma-ray detection scintillator with a coupling layer, sound-absorbing material, and collimator into a single probe. This allows for accurate lesion localization and real-time measurement throughout the surgical process with low radiation exposure.
This technology relates to a vehicle braking device that includes a cylinder body with hydraulic/pneumatic inlets, upper and lower plates, a fixing rod, a piston member, and a compression spring.
Existing vehicles faced risks of sliding when parked or stopped on slopes, or sudden acceleration accidents due to vehicle defects or operational errors.
To address this, this technology uses hydraulic/pneumatic pressure to move the piston member, lifting the drive wheels off the ground during parking/stopping or sudden acceleration, thereby fundamentally preventing human and property damage caused by sliding on slopes and sudden acceleration.
This technology relates to a method for synthesizing microparticles composed of a polymer network using fluid lithography.
There has been a demand for a method to uniformly manufacture microparticles capable of precisely binding various functional materials.
This technology involves a step of binding desired materials to the unreacted carbon double bond termini of the polymer network, enabling the efficient manufacturing of functionalized microparticles.
This technology is a three-step method for producing kidney organoids, involving differentiating stem cells into metanephric mesenchymal cells, forming cell aggregates, and then differentiating them into kidney organoids.
Existing kidney organoids have struggled to achieve proper structure and maturity due to their immaturity and limitations in nutrient supply.
This technology produces kidney organoids with improved structure and porosity through a stepwise differentiation protocol, making them applicable to kidney tissue models and related research.
This technology concerns lipid nanoparticles containing hyaluronic acid-lipid derivatives and their uses as carriers for delivering mRNA, proteins, and drugs into the body.
Existing mRNA vaccine delivery systems have faced issues with chronic immunogenicity, low protein expression rates, and stability.
This technology consists of hyaluronic acid-lipid derivatives, ionizable lipids, cholesterol, and phosphatidylcholine, and exhibits excellent mucosal adhesiveness and permeability, thereby enhancing mRNA stability and delivery efficiency and enabling nasal and pulmonary delivery.
This technology provides a method for producing bacteria-like particles that display fish pathogenic virus-derived antigens on their surface, produced in plants, and a fish vaccine composition containing these particles.
Traditional fish vaccination is labor-intensive, time-consuming, and costly, necessitating an orally administrable plant-based vaccine platform.
This technology produces bacteria-like particles in plants using Lactococcus lactis to display antigens, thereby providing an efficient vaccine platform for enhancing fish immunity.
